168 related articles for article (PubMed ID: 27049069)
1. The release of Doxorubicin from liposomes monitored by MRI and triggered by a combination of US stimuli led to a complete tumor regression in a breast cancer mouse model.
Rizzitelli S; Giustetto P; Faletto D; Delli Castelli D; Aime S; Terreno E
J Control Release; 2016 May; 230():57-63. PubMed ID: 27049069
[TBL] [Abstract][Full Text] [Related]
2. Sonosensitive theranostic liposomes for preclinical in vivo MRI-guided visualization of doxorubicin release stimulated by pulsed low intensity non-focused ultrasound.
Rizzitelli S; Giustetto P; Cutrin JC; Delli Castelli D; Boffa C; Ruzza M; Menchise V; Molinari F; Aime S; Terreno E
J Control Release; 2015 Mar; 202():21-30. PubMed ID: 25626083
[TBL] [Abstract][Full Text] [Related]
3. Combined delivery and magnetic resonance imaging of neural cell adhesion molecule-targeted doxorubicin-containing liposomes in experimentally induced Kaposi's sarcoma.
Grange C; Geninatti-Crich S; Esposito G; Alberti D; Tei L; Bussolati B; Aime S; Camussi G
Cancer Res; 2010 Mar; 70(6):2180-90. PubMed ID: 20215497
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive Imaging of Liposomal Delivery of Superparamagnetic Iron Oxide Nanoparticles to Orthotopic Human Breast Tumor in Mice.
Kato Y; Zhu W; Backer MV; Neoh CC; Hapuarachchige S; Sarkar SK; Backer JM; Artemov D
Pharm Res; 2015 Nov; 32(11):3746-3755. PubMed ID: 26078000
[TBL] [Abstract][Full Text] [Related]
5. Extensive preclinical investigation of polymersomal formulation of doxorubicin versus Doxil-mimic formulation.
Alibolandi M; Abnous K; Mohammadi M; Hadizadeh F; Sadeghi F; Taghavi S; Jaafari MR; Ramezani M
J Control Release; 2017 Oct; 264():228-236. PubMed ID: 28844758
[TBL] [Abstract][Full Text] [Related]
6. Dynamic contrast enhanced MRI detects changes in vascular transport rate constants following treatment with thermally-sensitive liposomal doxorubicin.
Fite BZ; Kheirolomoom A; Foiret JL; Seo JW; Mahakian LM; Ingham ES; Tam SM; Borowsky AD; Curry FE; Ferrara KW
J Control Release; 2017 Jun; 256():203-213. PubMed ID: 28395970
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging of high intensity focused ultrasound mediated drug delivery from temperature-sensitive liposomes: an in vivo proof-of-concept study.
de Smet M; Heijman E; Langereis S; Hijnen NM; Grüll H
J Control Release; 2011 Feb; 150(1):102-10. PubMed ID: 21059375
[TBL] [Abstract][Full Text] [Related]
8. Improved drug delivery and therapeutic efficacy of PEgylated liposomal doxorubicin by targeting anti-HER2 peptide in murine breast tumor model.
Zahmatkeshan M; Gheybi F; Rezayat SM; Jaafari MR
Eur J Pharm Sci; 2016 Apr; 86():125-35. PubMed ID: 26972276
[TBL] [Abstract][Full Text] [Related]
9. Accumulation, internalization and therapeutic efficacy of neuropilin-1-targeted liposomes.
Paoli EE; Ingham ES; Zhang H; Mahakian LM; Fite BZ; Gagnon MK; Tam S; Kheirolomoom A; Cardiff RD; Ferrara KW
J Control Release; 2014 Mar; 178():108-17. PubMed ID: 24434424
[TBL] [Abstract][Full Text] [Related]
10. MR-labelled liposomes and focused ultrasound for spatiotemporally controlled drug release in triple negative breast cancers in mice.
Amrahli M; Centelles M; Cressey P; Prusevicius M; Gedroyc W; Xu XY; So PW; Wright M; Thanou M
Nanotheranostics; 2021; 5(2):125-142. PubMed ID: 33457192
[No Abstract] [Full Text] [Related]
11. Surrogate MRI markers for hyperthermia-induced release of doxorubicin from thermosensitive liposomes in tumors.
Peller M; Willerding L; Limmer S; Hossann M; Dietrich O; Ingrisch M; Sroka R; Lindner LH
J Control Release; 2016 Sep; 237():138-46. PubMed ID: 27364227
[TBL] [Abstract][Full Text] [Related]
12. Method of hyperthermia and tumor size influence effectiveness of doxorubicin release from thermosensitive liposomes in experimental tumors.
Willerding L; Limmer S; Hossann M; Zengerle A; Wachholz K; Ten Hagen TL; Koning GA; Sroka R; Lindner LH; Peller M
J Control Release; 2016 Jan; 222():47-55. PubMed ID: 26658073
[TBL] [Abstract][Full Text] [Related]
13. An acoustic/thermo-responsive hybrid system for advanced doxorubicin delivery in tumor treatment.
Zhang L; Zhang S; Chen H; Liang Y; Zhao B; Luo W; Xiao Q; Li J; Zhu J; Peng C; Zhang Y; Hong Z; Wang Y; Li Y
Biomater Sci; 2020 Apr; 8(8):2202-2211. PubMed ID: 32100739
[TBL] [Abstract][Full Text] [Related]
14. Temperature-sensitive liposomes for doxorubicin delivery under MRI guidance.
de Smet M; Langereis S; van den Bosch S; Grüll H
J Control Release; 2010 Apr; 143(1):120-7. PubMed ID: 19969035
[TBL] [Abstract][Full Text] [Related]
15. Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin.
Arabi L; Badiee A; Mosaffa F; Jaafari MR
J Control Release; 2015 Dec; 220(Pt A):275-286. PubMed ID: 26518722
[TBL] [Abstract][Full Text] [Related]
16. Comparative plasma and tissue distribution of Sun Pharma's generic doxorubicin HCl liposome injection versus Caelyx
Burade V; Bhowmick S; Maiti K; Zalawadia R; Jain D; Rajamannar T
Cancer Chemother Pharmacol; 2017 May; 79(5):899-913. PubMed ID: 28349166
[TBL] [Abstract][Full Text] [Related]
17. Iron(III)-Based Magnetic Resonance-Imageable Liposomal T1 Contrast Agent for Monitoring Temperature-Induced Image-Guided Drug Delivery.
Kneepkens E; Fernandes A; Nicolay K; Grüll H
Invest Radiol; 2016 Nov; 51(11):735-745. PubMed ID: 27309776
[TBL] [Abstract][Full Text] [Related]
18. Pegylated liposomal formulation of doxorubicin overcomes drug resistance in a genetically engineered mouse model of breast cancer.
Füredi A; Szebényi K; Tóth S; Cserepes M; Hámori L; Nagy V; Karai E; Vajdovich P; Imre T; Szabó P; Szüts D; Tóvári J; Szakács G
J Control Release; 2017 Sep; 261():287-296. PubMed ID: 28700899
[TBL] [Abstract][Full Text] [Related]
19. Lipid bubbles combined with low-intensity ultrasound enhance the intratumoral accumulation and antitumor effect of pegylated liposomal doxorubicin
Yokoe I; Omata D; Unga J; Suzuki R; Maruyama K; Okamoto Y; Osaki T
Drug Deliv; 2021 Dec; 28(1):530-541. PubMed ID: 33685314
[TBL] [Abstract][Full Text] [Related]
20. Sequential HIFU heating and nanobubble encapsulation provide efficient drug penetration from stealth and temperature sensitive liposomes in colon cancer.
VanOsdol J; Ektate K; Ramasamy S; Maples D; Collins W; Malayer J; Ranjan A
J Control Release; 2017 Feb; 247():55-63. PubMed ID: 28042085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
